Physician
Mankato Clinic LTD
Mankato Clinic LTD was paid $39.10M by Medicaid between Jan 2018 and Dec 2024, across 307 billing codes. Its largest line is 99214, doctor's office visit, returning patient (more involved) — 28% of everything it billed.
33Billing provider infoMANKATO CLINIC LTD
MANKATO, MN 56001
MANKATO, MN 56001
33aNPI1629044029assigned 02/24/2006
33bProvider typePediatrics Physician
28Total paid$39.10M
24GClaims1,133,206
24DCodes billed307
24AFirst – last monthJan 2018 – Dec 2024
Compared with peers
Next to other Pediatrics Physician providers in Minnesota
Rank by total paid#1 of 33
Median peer was paid$13K
This provider vs. median2,970×
Peers share this provider's primary NPPES type and state. Size alone says nothing about billing quality: a big agency or a hospital system is expected to sit far above the median.
Box 24A · Dates of service
Paid by month
Paid that monthNov–Dec 2024: claims still arriving when the file was cut, so these months run low for every provider
By year, as a table
| Year | Claims | Paid | |
|---|---|---|---|
| 2018 | 176,209 | $1.94M | |
| 2019 | 184,201 | $6.21M | |
| 2020 | 168,279 | $5.86M | |
| 2021 | 199,160 | $7.36M | |
| 2022 | 166,756 | $6.64M | |
| 2023 | 136,080 | $6.11M | |
| 2024incomplete | 102,521 | $4.99M |
Box 24 · Service lines
What it billed for
| Code | Service | Share | Claims | Bene. records | Paid |
|---|---|---|---|---|---|
| 99214 | Doctor's office visit, returning patient (more involved)Office or other outpatient visit for the evaluation and management of an established patient, moderate complexity | 28% | 153,489 | 136,573 | $10.99M |
| 99213 | Doctor's office visit, returning patient (routine)Office or other outpatient visit for the evaluation and management of an established patient, low complexity | 14% | 112,495 | 101,754 | $5.47M |
| 90833 | Psychotherapy, 30 minutes with patient when performed with an E&M service (add-on) | 4.6% | 27,135 | 25,752 | $1.81M |
| 97530 | Therapeutic activities, direct patient contact, each 15 minutes | 3.7% | 27,325 | 9,844 | $1.46M |
| 92507 | Treatment of speech, language, voice, communication, and/or auditory processing disorder | 3.0% | 23,663 | 8,405 | $1.17M |
| 99337 | 3.0% | 14,722 | 13,857 | $1.17M | |
| X5622 | 2.6% | 12,376 | 11,603 | $1.01M | |
| S0302 | Completed early periodic screening diagnosis and treatment (epsdt) service (list in addition to code for appropriate evaluation and management service) | 2.3% | 34,007 | 32,266 | $891K |
| 99215 | Doctor's office visit, returning patient (complex)Prolong outpt/office vis | 1.8% | 8,423 | 7,868 | $714K |
| 99392 | Periodic comprehensive preventive medicine reevaluation, established patient, early childhood (1-4 years) | 1.5% | 9,056 | 8,810 | $593K |
| 90837 | Psychotherapy session, about an hourPsychotherapy, 53 minutes with patient | 1.3% | 5,909 | 4,730 | $515K |
| 90460 | Immunization administration through 18 years of age via any route, first or only component | 1.3% | 17,910 | 17,336 | $493K |
295 more codes
| 90836 | 1.2% | 5,966 | $475K | |
| 99203 | Doctor's office visit, new patient (routine) | 1.2% | 7,388 | $464K |
| 99350 | Prolong home eval add 15m | 1.2% | 4,668 | $459K |
| 87635 | Infectious agent detection by nucleic acid; SARS-CoV-2 (COVID-19), amplified probe | 1.1% | 9,399 | $449K |
| 99244 | Office or other outpatient consultation, moderate to high complexity | 1.0% | 3,383 | $399K |
| 90834 | Psychotherapy session, about 45 minutes | <1% | 7,560 | $381K |
| 99391 | Periodic comprehensive preventive medicine reevaluation, established patient, infant (under 1 year) | <1% | 7,431 | $366K |
| 99393 | Periodic comprehensive preventive medicine reevaluation, established patient, late childhood (5-11 years) | <1% | 5,914 | $363K |
| 92014 | Ophthalmological services: medical examination and evaluation, comprehensive, established patient | <1% | 5,152 | $354K |
| J0585 | Injection, onabotulinumtoxina, 1 unit | <1% | 391 | $320K |
| T1013 | Sign language or oral interpretive services, per 15 minutes | <1% | 7,009 | $304K |
| 87651 | Infectious agent detection by nucleic acid; Streptococcus, group A, amplified probe | <1% | 8,823 | $292K |
| 99396 | Periodic comprehensive preventive medicine reevaluation, established patient, 40-64 years | <1% | 2,999 | $243K |
| 99395 | Periodic comprehensive preventive medicine reevaluation, established patient, 18-39 years | <1% | 3,265 | $243K |
| 0241U | Neonatal screening for hereditary disorders, genomic sequence analysis panel | <1% | 1,693 | $231K |
| 77067 | Screening mammography, bilateral, including computer-aided detection | <1% | 3,125 | $228K |
| 97112 | Therapeutic procedure, each 15 minutes; neuromuscular reeducation of movement, balance, coordination | <1% | 8,050 | $225K |
| 36415 | Collection of venous blood by venipuncture | <1% | 75,948 | $219K |
| 99394 | Periodic comprehensive preventive medicine reevaluation, established patient, adolescent (12-17 years) | <1% | 3,359 | $218K |
| 99309 | Subsequent nursing facility care, per day, low to moderate complexity | <1% | 4,588 | $208K |
| 99204 | Doctor's office visit, new patient (more involved) | <1% | 2,226 | $205K |
| 99310 | Prolong nursin fac eval 15m | <1% | 2,112 | $169K |
| 90471 | Immunization administration (includes percutaneous, intradermal, subcutaneous, or intramuscular injections), 1 vaccine | <1% | 12,598 | $168K |
| 97110 | Therapeutic procedure, each 15 minutes; therapeutic exercises to develop strength and endurance, flexibility and range of motion | <1% | 7,923 | $167K |
| 99243 | <1% | 2,139 | $162K | |
| 90832 | Psychotherapy session, about 30 minutes | <1% | 3,188 | $147K |
| 17110 | <1% | 2,291 | $147K | |
| 80053 | Comprehensive metabolic panel | <1% | 20,410 | $146K |
| 99202 | Office or other outpatient visit for the evaluation and management of a new patient, straightforward | <1% | 3,483 | $128K |
| 87491 | Infectious agent detection by nucleic acid; Chlamydia trachomatis, amplified probe | <1% | 4,219 | $126K |
| 84443 | Thyroid stimulating hormone (TSH) | <1% | 10,980 | $125K |
| 92004 | Ophthalmological services: medical examination and evaluation, comprehensive, new patient | <1% | 1,391 | $124K |
| 97140 | Manual therapy techniques, each 15 minutes (e.g., mobilization/manipulation, manual lymphatic drainage) | <1% | 5,553 | $124K |
| 99349 | <1% | 1,938 | $123K | |
| 88305 | Level IV - Surgical pathology, gross and microscopic examination | <1% | 1,640 | $123K |
| 90461 | <1% | 8,983 | $122K | |
| 87591 | Infectious agent detection by nucleic acid; Neisseria gonorrhoeae, amplified probe | <1% | 4,064 | $122K |
| 92012 | Ophthalmological services: medical examination and evaluation, intermediate, established patient | <1% | 2,268 | $115K |
| G0439 | Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | <1% | 3,423 | $114K |
| 97535 | Self-care/home management training, each 15 minutes | <1% | 4,732 | $109K |
| 87880 | Infectious agent antigen detection by immunoassay; Streptococcus, group A | <1% | 10,239 | $109K |
| 80061 | Lipid panel | <1% | 13,196 | $107K |
| 90791 | Psychiatric diagnostic evaluation | <1% | 981 | $100K |
| 71046 | Radiologic examination, chest; 2 views | <1% | 5,306 | $96K |
| 85025 | Blood count; complete (CBC), automated, and automated differential WBC count | <1% | 19,081 | $93K |
| 92551 | <1% | 16,175 | $87K | |
| 92015 | Determination of refractive state | <1% | 7,140 | $83K |
| 87480 | <1% | 4,864 | $82K | |
| 87510 | <1% | 4,865 | $82K | |
| 83036 | Hemoglobin; glycosylated (A1C) | <1% | 13,358 | $82K |
| 85027 | <1% | 18,002 | $81K | |
| 87660 | <1% | 4,678 | $81K | |
| 96127 | <1% | 18,725 | $78K | |
| 77063 | Screening digital breast tomosynthesis, bilateral | <1% | 2,466 | $75K |
| 99242 | <1% | 1,440 | $73K | |
| 99308 | Subsequent nursing facility care, per day, straightforward | <1% | 2,005 | $68K |
| 99336 | <1% | 1,076 | $66K | |
| 76816 | Ultrasound, pregnant uterus, real time with image documentation, follow-up | <1% | 881 | $65K |
| 87088 | <1% | 10,533 | $62K | |
| 80048 | Basic metabolic panel (calcium, ionized) | <1% | 11,121 | $60K |
| 90686 | <1% | 12,014 | $60K | |
| 82306 | Vitamin D; 25 hydroxy, includes fraction(s), if performed | <1% | 2,628 | $56K |
| 96110 | Developmental screening, with scoring and documentation, per standardized instrument | <1% | 9,242 | $55K |
| 99335 | <1% | 1,382 | $54K | |
| 87804 | Infectious agent antigen detection by immunoassay; Influenza, each type | <1% | 4,566 | $54K |
| 76856 | Ultrasound, pelvic (nonobstetric), real time with image documentation; complete | <1% | 830 | $51K |
| 90960 | End-stage renal disease related services monthly, for patients 20 years and older, with 4 or more face-to-face visits | <1% | 414 | $51K |
| 76830 | Ultrasound, transvaginal | <1% | 679 | $50K |
| 96372 | Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular | <1% | 6,466 | $50K |
| 64405 | <1% | 1,289 | $47K | |
| J1050 | Injection, medroxyprogesterone acetate, 1 mg | <1% | 732 | $46K |
| 82728 | <1% | 3,340 | $38K | |
| 99212 | Office or other outpatient visit for the evaluation and management of an established patient, straightforward | <1% | 1,580 | $36K |
| 99188 | <1% | 14,381 | $36K | |
| 92340 | Fitting of spectacles, except for aphakia; monofocal | <1% | 1,394 | $36K |
| 90651 | <1% | 2,152 | $35K | |
| 99495 | <1% | 480 | $35K | |
| 74177 | Computed tomography, abdomen and pelvis; with contrast material | <1% | 195 | $34K |
| 97803 | <1% | 668 | $34K | |
| 90715 | <1% | 2,503 | $33K | |
| 81001 | <1% | 14,467 | $32K | |
| 87389 | Infectious agent antigen detection by immunoassay technique, HIV-1 antigen with HIV-1 and HIV-2 antibodies | <1% | 1,552 | $32K |
| 99490 | Ccm add 20min | <1% | 2,152 | $29K |
| 97597 | <1% | 597 | $28K | |
| 96365 | Intravenous infusion, for therapy, prophylaxis, or diagnosis; initial, up to 1 hour | <1% | 702 | $28K |
| 93306 | Echocardiography, transthoracic, real-time with image documentation, with and without Doppler, complete | <1% | 233 | $27K |
| 84703 | <1% | 4,157 | $26K | |
| 99402 | <1% | 522 | $26K | |
| 85610 | <1% | 9,412 | $26K | |
| 90792 | Psychiatric diagnostic evaluation with medical services | <1% | 127 | $24K |
| 87081 | <1% | 3,439 | $23K | |
| 93793 | <1% | 3,082 | $21K | |
| 82607 | <1% | 1,895 | $21K | |
| 90472 | Immunization administration, each additional vaccine (list separately) | <1% | 1,515 | $20K |
| 74018 | <1% | 1,134 | $20K | |
| 83655 | <1% | 1,281 | $19K | |
| 87077 | <1% | 3,259 | $19K | |
| 27096 | <1% | 272 | $18K | |
| 95251 | <1% | 985 | $18K | |
| 67028 | Intravitreal injection of a pharmacologic agent | <1% | 259 | $17K |
| V5266 | Battery for use in hearing device | <1% | 698 | $16K |
| 76805 | Ultrasound, pregnant uterus, real time with image documentation, fetal and maternal evaluation | <1% | 168 | $16K |
| 93000 | <1% | 1,958 | $16K | |
| 73630 | <1% | 847 | $15K | |
| 99401 | <1% | 513 | $15K | |
| 20553 | <1% | 961 | $14K | |
| 83550 | <1% | 1,954 | $14K | |
| 99173 | <1% | 15,191 | $14K | |
| 99152 | <1% | 1,699 | $13K | |
| 95004 | Percutaneous tests with allergenic extracts, immediate type reaction | <1% | 136 | $12K |
| 90670 | <1% | 5,310 | $12K | |
| 84439 | <1% | 1,588 | $11K | |
| U0003 | Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, making use of high throughput technologies as described by cms-2020-01-r | <1% | 127 | $11K |
| 97161 | <1% | 174 | $11K | |
| 83540 | <1% | 2,018 | $11K | |
| 99245 | <1% | 45 | $11K | |
| 69436 | Tympanostomy (requiring insertion of ventilating tube), general anesthesia | <1% | 79 | $10K |
| 92567 | <1% | 1,202 | $10K | |
| 97802 | <1% | 149 | $10K | |
| 0001A | <1% | 355 | $10K | |
| 76815 | Ultrasound, pregnant uterus, real time with image documentation, limited | <1% | 169 | $9K |
| 84702 | <1% | 678 | $9K | |
| 0352U | <1% | 69 | $9K | |
| 90662 | <1% | 262 | $8K | |
| Q9967 | Low osmolar contrast material, 300-399 mg/ml iodine concentration, per ml | <1% | 819 | $8K |
| 64635 | <1% | 67 | $8K | |
| 97533 | <1% | 244 | $8K | |
| 99454 | <1% | 225 | $8K | |
| 0071A | <1% | 214 | $7K | |
| 0002A | <1% | 243 | $7K | |
| 86140 | <1% | 1,623 | $7K | |
| 99457 | <1% | 217 | $7K | |
| 99174 | <1% | 2,223 | $7K | |
| 0072A | <1% | 166 | $6K | |
| 76819 | Fetal biophysical profile; without non-stress testing | <1% | 105 | $6K |
| 92523 | <1% | 60 | $6K | |
| 99381 | <1% | 594 | $6K | |
| 82570 | <1% | 1,637 | $6K | |
| 62321 | <1% | 106 | $6K | |
| 96413 | Chemotherapy administration, intravenous infusion; up to 1 hour, single or initial substance | <1% | 70 | $6K |
| 76642 | <1% | 115 | $6K | |
| 62323 | <1% | 112 | $6K | |
| J9035 | Injection, bevacizumab, 10 mg | <1% | 104 | $6K |
| 87807 | <1% | 457 | $5K | |
| G2211 | Visit complexity inherent to evaluation and management associated with medical care services that serve as the continuing focal point for all needed health care services and/or with medical care services that are part of ongoing care related to a patient's single, serious condition or a complex condition. (add-on code, list separately in addition to office/outpatient evaluation and management visit, new or established) | <1% | 969 | $5K |
| 42820 | Tonsillectomy and adenoidectomy; younger than age 12 | <1% | 29 | $5K |
| 90734 | <1% | 1,431 | $5K | |
| 83970 | <1% | 173 | $5K | |
| 85018 | <1% | 2,355 | $4K | |
| 87340 | <1% | 509 | $4K | |
| 96160 | <1% | 2,432 | $4K | |
| 95886 | <1% | 40 | $4K | |
| 84156 | <1% | 1,373 | $4K | |
| 90847 | Family psychotherapy with the patient present, 50 minutes | <1% | 96 | $4K |
| 64450 | <1% | 132 | $4K | |
| 87186 | <1% | 1,103 | $4K | |
| 90785 | <1% | 322 | $4K | |
| 86592 | <1% | 927 | $4K | |
| 64636 | <1% | 67 | $3K | |
| 99417 | Prolong home eval add 15m | <1% | 67 | $3K |
| 99334 | <1% | 82 | $3K | |
| 86780 | <1% | 336 | $3K | |
| 92134 | <1% | 139 | $3K | |
| 0004A | <1% | 102 | $3K | |
| 64615 | <1% | 39 | $3K | |
| 85651 | <1% | 937 | $3K | |
| G0008 | Administration of influenza virus vaccine | <1% | 1,084 | $3K |
| 92557 | <1% | 162 | $3K | |
| 97165 | <1% | 56 | $3K | |
| 83735 | <1% | 549 | $3K | |
| 84153 | <1% | 218 | $3K | |
| 90621 | <1% | 216 | $3K | |
| 92250 | <1% | 133 | $3K | |
| 92341 | <1% | 86 | $3K | |
| 43239 | Esophagogastroduodenoscopy, flexible, transoral; with biopsy, single or multiple | <1% | 41 | $3K |
| 82746 | <1% | 250 | $2K | |
| 90716 | <1% | 675 | $2K | |
| 36416 | <1% | 1,298 | $2K | |
| 97162 | <1% | 64 | $2K | |
| 77002 | <1% | 141 | $2K | |
| 87653 | <1% | 63 | $2K | |
| 0064A | <1% | 103 | $2K | |
| 95117 | <1% | 241 | $2K | |
| 99232 | Hospital visit by a doctor, follow-up day | <1% | 38 | $2K |
| 92593 | <1% | 81 | $2K | |
| 96375 | Therapeutic injection; each additional sequential IV push | <1% | 135 | $2K |
| 99348 | <1% | 49 | $2K | |
| 86803 | <1% | 121 | $2K | |
| 90838 | <1% | 14 | $2K | |
| 72148 | Magnetic resonance imaging, lumbar spine; without contrast material | <1% | 15 | $2K |
| 86850 | <1% | 237 | $2K | |
| 73610 | <1% | 77 | $2K | |
| 99211 | Office or other outpatient visit for the evaluation and management of an established patient, minimal severity | <1% | 88 | $2K |
| 80050 | General health panel | <1% | 86 | $2K |
| 76817 | Ultrasound, pregnant uterus, real time with image documentation, transvaginal | <1% | 45 | $2K |
| 45380 | Colonoscopy, flexible; with biopsy, single or multiple | <1% | 12 | $2K |
| 59025 | Fetal non-stress test | <1% | 52 | $1K |
| 94010 | <1% | 151 | $1K | |
| 99439 | <1% | 71 | $1K | |
| V2020 | Frames, purchases | <1% | 44 | $1K |
| L3030 | Foot, insert, removable, formed to patient foot, each | <1% | 13 | $1K |
| 99383 | <1% | 12 | $1K | |
| 99382 | <1% | 13 | $1K | |
| 73564 | <1% | 44 | $1K | |
| 90656 | <1% | 441 | $1K | |
| J1756 | Injection, iron sucrose, 1 mg | <1% | 30 | $1K |
| 90473 | <1% | 72 | $1K | |
| 84450 | <1% | 356 | $1K | |
| 90707 | <1% | 519 | $986.24 | |
| 83690 | <1% | 174 | $973.10 | |
| 11100 | <1% | 205 | $958.63 | |
| 94640 | Pressurized or nonpressurized inhalation treatment for acute airway obstruction | <1% | 133 | $942.24 |
| 64493 | <1% | 12 | $908.67 | |
| 84100 | <1% | 291 | $898.72 | |
| 90677 | <1% | 270 | $886.86 | |
| 76811 | Ultrasound, pregnant uterus, real time with image documentation, fetal and maternal evaluation, detailed | <1% | 51 | $885.30 |
| 86762 | <1% | 94 | $825.84 | |
| 70450 | Computed tomography, head or brain; without contrast material | <1% | 13 | $799.81 |
| 11102 | <1% | 13 | $794.70 | |
| 92504 | <1% | 52 | $775.48 | |
| 64490 | <1% | 13 | $763.19 | |
| 96374 | Therapeutic, prophylactic, or diagnostic injection; intravenous push, single or initial substance | <1% | 27 | $702.27 |
| 82565 | <1% | 166 | $688.57 | |
| S0281 | Medical home program, comprehensive care coordination and planning, maintenance of plan | <1% | 88 | $654.84 |
| 73130 | <1% | 26 | $605.68 | |
| 84460 | <1% | 146 | $590.76 | |
| 85007 | <1% | 194 | $586.71 | |
| 69209 | <1% | 111 | $586.43 | |
| V2784 | Lens, polycarbonate or equal, any index, per lens | <1% | 21 | $580.00 |
| 90698 | <1% | 4,690 | $567.98 | |
| 86901 | <1% | 247 | $553.50 | |
| 82950 | <1% | 120 | $553.33 | |
| 90680 | <1% | 3,338 | $534.33 | |
| 0054A | <1% | 13 | $519.68 | |
| 82947 | <1% | 138 | $505.11 | |
| 0012A | <1% | 73 | $492.73 | |
| 0134A | <1% | 26 | $489.25 | |
| 86900 | <1% | 210 | $481.72 | |
| 0124A | <1% | 12 | $477.97 | |
| 99459 | <1% | 109 | $477.09 | |
| 84550 | <1% | 162 | $476.96 | |
| J3301 | Injection, triamcinolone acetonide, not otherwise specified, 10 mg | <1% | 239 | $476.38 |
| G2012 | Brief communication technology-based service, e.g. virtual check-in, by a physician or other qualified health care professional who can report evaluation and management services, provided to an established patient, not originating from a related e/m service provided within the previous 7 days nor leading to an e/m service or procedure within the next 24 hours or soonest available appointment; 5-10 minutes of medical discussion | <1% | 58 | $422.72 |
| 69210 | <1% | 13 | $414.15 | |
| 0011A | <1% | 62 | $413.02 | |
| 87797 | <1% | 162 | $390.00 | |
| 90672 | <1% | 560 | $336.91 | |
| 95874 | <1% | 17 | $336.77 | |
| 73110 | <1% | 14 | $330.58 | |
| 97116 | <1% | 17 | $312.00 | |
| G0500 | Moderate sedation services provided by the same physician or other qualified health care professional performing a gastrointestinal endoscopic service that sedation supports, requiring the presence of an independent trained observer to assist in the monitoring of the patient's level of consciousness and physiological status; initial 15 minutes of intra-service time; patient age 5 years or older (additional time may be reported with 99153, as appropriate) | <1% | 117 | $274.77 |
| 84132 | <1% | 54 | $270.75 | |
| 73030 | <1% | 14 | $266.22 | |
| 82310 | <1% | 51 | $253.25 | |
| 84295 | <1% | 48 | $236.56 | |
| 90480 | <1% | 18 | $234.78 | |
| 90633 | <1% | 2,622 | $231.98 | |
| 82374 | <1% | 46 | $229.66 | |
| A9585 | Injection, gadobutrol, 0.1 ml | <1% | 26 | $226.03 |
| 90710 | <1% | 641 | $222.08 | |
| 82435 | <1% | 44 | $206.96 | |
| 82040 | <1% | 37 | $180.94 | |
| 84075 | <1% | 30 | $162.98 | |
| 82247 | <1% | 30 | $158.10 | |
| 84484 | <1% | 12 | $151.32 | |
| J1885 | Injection, ketorolac tromethamine, per 15 mg | <1% | 207 | $148.89 |
| 70553 | Magnetic resonance imaging, brain; without contrast material, followed by contrast material and further sequences | <1% | 12 | $145.28 |
| G0438 | Annual wellness visit; includes a personalized prevention plan of service (pps), initial visit | <1% | 254 | $144.75 |
| 90697 | <1% | 245 | $144.05 | |
| 85379 | <1% | 13 | $133.73 | |
| 87071 | <1% | 73 | $128.26 | |
| G0103 | Prostate cancer screening; prostate specific antigen test (psa) | <1% | 27 | $124.96 |
| 84155 | <1% | 30 | $115.60 | |
| 84165 | <1% | 12 | $92.45 | |
| 82274 | <1% | 12 | $80.92 | |
| 84478 | <1% | 14 | $67.87 | |
| 82043 | <1% | 14 | $63.60 | |
| 90744 | <1% | 2,203 | $28.23 | |
| 1160F | 0% | 19,804 | $0.00 | |
| 90685 | 0% | 706 | $0.00 | |
| 91321 | 0% | 17 | $0.00 | |
| 80164 | 0% | 94 | $0.00 | |
| H1002 | Prenatal care, at risk enhanced service; care coordination | 0% | 12 | $0.00 |
| 1124F | 0% | 51 | $0.00 | |
| H1003 | Prenatal care, at-risk enhanced service; education | 0% | 12 | $0.00 |
| 1111F | 0% | 3,750 | $0.00 | |
| 1157F | 0% | 8,673 | $0.00 | |
| 90696 | 0% | 663 | $0.00 | |
| 99070 | 0% | 76 | $0.00 | |
| H1001 | Prenatal care, at-risk enhanced service; antepartum management | 0% | 12 | $0.00 |
| 90619 | 0% | 98 | $0.00 | |
| 90381 | 0% | 14 | $0.00 | |
| 86308 | 0% | 13 | $0.00 | |
| 59400 | Routine obstetric care including antepartum care, vaginal delivery, and postpartum care | 0% | 14 | $0.00 |
| 90660 | 0% | 13 | $0.00 |
Claims and beneficiary counts add up across code × month rows, so one patient seen every month counts many times. Rows with fewer than 12 claims are suppressed by HHS, so small lines can be missing.
From NPPES
Who's on the registration
Authorized officialJOHNSON, AARON (CEO)